What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?

American Journal of Surgery

Volumn 192, Issue 4, 2006, Pages 455-457

  Mabry, Helen ^a   Giuliano, Armando E ^a   Silverstein, Melvin J ^b  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Breast; Cancer; DCIS; Ductal carcinoma in situ; Sentinel node biopsy; SNB

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; DUCTAL CARCINOMA IN SITU; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 33748439244     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2006.06.028     Document Type: Article

References (16)

1. Pendas S., Dauway E., Giuliano R., et al. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 7 (2000) 15-20
2. Klauber-DeMore N., Tan L.K., Liberman L., et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?. Ann Surg Oncol 7 (2000) 636-642
3. Cox C.E., Nguyen K., Gray R.J., et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?. Am Surg 67 (2001) 513-519
4. Kelly T.A., Kim J.A., Patrick R., et al. Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ. Am J Surg 186 (2003) 368-370
5. Veronesi P., Intra M., Vento A.R., et al. Sentinel lymph node biopsy for localized ductal carcinoma in situ?. Breast 14 (2005) 520-522
6. Wilkie C., White L., Dupont E., et al. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 190 (2005) 563-566
7. Zavagno G., Carcoforo P., Marconato R., et al. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma of the breast. BMC Cancer 5 (2005) 28
8. Intra M., Veronesi P., Mazzarol G., et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma of the breast. Arch Surg 138 (2003) 309-313
9. Farkas E.A., Stolier A.J., Teng S.C., et al. An argument against routine sentinel node mapping for DCIS. Am Surg 70 (2004) 13-17
10. Silverstein M.J., Gierson E.D., Colburn W.J., et al. Axillary lymphadenectomy for intraductal carcinoma of the breast. Surg Gynecol Obstetrics 172 (1999) 211-214
11. Mittendorf E.A., Arciero C.A., Gutchell V., et al. Core biopsy of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg 62 (2005) 253-257
12. Wong S.L., Edwards M.J., Chao C., et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol 9 (2002) 272-277
13. Schwartz G.F., Giuliano A.E., Veronesi U., and Consensus Conference Committee. Breast J 8 (2002) 126-138 Proceedings of the Consensus Conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, PA, USA
14. Yen T.W.F., Hunt K.K., Ross M.I., et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200 (2005) 516-526
15. Lyman G.H., Giuliano A.E., Somerfield M.R., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23 (2005) 7703-7720
16. Lara J.F., Young S.M., Velilla R.E., et al. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up. Cancer 98 (2003) 2105-2113